Department of Health and Human Services
Agency Tracking Number:
Solicitation Topic Code:
Small Business Information
100 RIVER PLACE, SUITE 6800, DETROIT, MI, 48207-
Socially and Economically Disadvantaged:
AbstractApoLife is developing yeast platform-Twin Cassette yeast vectors for cost effective manufacturing of antibodies. Using recent collaboration with a company with proprietary S. cerevisiae yeast strains producing homogeneous human N-linked glycosylated proteins, ApoLife will develop commercial scale process for cost effective manufacturing of Campth, anticancer antibody, as a biogeneric antibody candidate. ApoLife has expressed Campath genes in yeast system.
* information listed above is at the time of submission.